HR Execs on the Move


 
Alto is a Dallas-based ridesharing company founded in 2018 by Will Coleman and Alexandra Halbardier. It operates primarily in Dallas and Houston, focusing on providing on-demand rideshare services through its app. Alto employs professional drivers as W-2 employees and maintains a proprietary fleet of luxury SUVs, ensuring high standards of safety and service. The company emphasizes safety with 5-star crash-rated vehicles, real-time video monitoring, and professionally trained drivers. Alto has exclusive curbside pickup rights at Dallas Love Field Airport, enhancing its service offerings. With a workforce of over 300 employees, Alto aims to deliver a premium transportation experience, differentiating itself from ...
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Svc Technique De B

Svc Technique De B is a Laval, QC-based company in the Business Services sector.

Mural Oncology

We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)

Your Health

Feel Better About Your Health In Your Home | Physicians Office | Telehealth

gtc technology group inc

gtc technology group inc is a Houston, TX-based company in the Business Services sector.

RBC